非处方药和膳食补充剂市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00012956
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 200
Buy Now

2019年非处方药和膳食补充剂市场价值为29325540万美元,预计到2027年将达到49210249万美元;预计 2020 年至 2027 年复合年增长率为 6.8%。

非处方药 (OTC) 可供公众一般使用。这些药物不需要医生处方。 OTC 药品可用于各种医疗用途咳嗽和感冒、腹泻、胃灼热、便秘、痤疮、疼痛等病症。另一方面,出于健身目的,膳食补充剂可以在柜台购买。然而,当一个人病情危重或需要治疗时,购买含有药用成分的膳食补充剂需要医生的处方。这些非处方药和营养补充剂有两种形式:品牌或仿制药。

非处方药和膳食补充剂市场的范围包括产品、类型、形式、分销渠道和地区。根据北美、欧洲、亚太地区、中东和美国等地区对非处方药和膳食补充剂市场进行了分析。非洲、南美洲和中美洲。该报告提供了对非处方药和膳食补充剂市场的见解和深入分析,重点关注市场趋势、技术进步、市场动态以及全球领先市场参与者的竞争格局分析等各种参数。

战略洞察

非处方药和膳食补充剂市场利润丰厚的区域


市场洞察

人们对一般健康问题的认识不断提高

现在,人们对感冒、咳嗽、过敏、发烧、疼痛、胃酸过多、腹泻和皮肤相关疾病等一般健康问题非常了解。大多数人都注重健康的生活方式,避免食用垃圾食品,因为垃圾食品会导致糖尿病、肥胖和心血管疾病等与生活方式相关的疾病增加。人们越来越倾向于保持健康的生活方式,这也导致了减肥产品和膳食补充剂的消费,例如维生素、矿物质和补充剂。互联网接触的增加使得消费者能够以实惠的价格获得膳食补充剂和非处方药 (OTC)。

常见的健康问题可以是季节性的,或者可能是由于日常习惯的微小变化而发生;因此,人们更喜欢服用非处方药来治疗,而不是去看医生。在许多情况下,这可以节省时间和金钱,并可以立即缓解压力。一些政府启动了各种提高健康意识的计划,因此医疗保健和健康领域的日常技术得以快速、顺利地采用,从而促进了该行业的整体增长。例如,在印度,政府正在采取积极措施,使非处方药的使用正规化。处方监控计划 (PMP) 收集、监控和分析药房和配药从业人员以电子方式传输的处方和配药数据。然后,该数据用于防止非处方药滥用。因此,促进了非处方药的销售。

制药行业的进步,如预测模型、移动应用程序、机器人和诊断,为药剂师开辟了新的途径,这可以提高他们分配药物的能力,最大限度地减少错误并监控患者的依从性。正确分配药品不会导致任何类型的药物滥用,这进一步增强了人们重新购买非处方药产品和膳食补充剂的信心。因此,人们对普遍健康问题的认识和制药行业的进步正在推动市场增长。

                             &n公共服务提供商;              

基于非处方药和膳食补充剂产品的见解     ;                   < /p>

根据产品,非处方药和膳食补充剂市场分为咳嗽和感冒产品、维生素和膳食补充剂、镇痛药、胃肠产品、助眠剂、口腔护理产品、眼科产品、抗酸剂、女性护理、

2019年,镇痛药细分市场占据最高份额。该细分市场的增长归因于人们对一般健康问题的认识不断增强,以及全世界对非处方药的偏好超过处方药。然而,在预测期内,维生素和膳食补充剂细分市场可能在全球非处方药和膳食补充剂市场中实现最高的复合年增长率。

                           &n公共服务提供商;                   &n公共服务提供商;                   &n公共服务提供商;            

全球非处方药和膳食补充剂市场,按非处方药和膳食补充剂类型划分– 2019年& 2027


基于类型的见解

根据类型,非处方药和膳食补充剂市场分为品牌药和仿制药。 2019 年,仿制药细分市场占据了更大的市场份额;然而,预计在预测期内,同一细分市场的复合年增长率将达到 7.1%。

基于剂型的见解

根据剂型,非处方药和膳食补充剂市场分为片剂、胶囊、粉末、软膏、液体, 和别的。平板电脑细分市场在 2019 年占据最大市场份额,预计在预测期内复合年增长率最高,为 7.5%。

            ;                      ;        

根据分销渠道,非处方药和膳食补充剂市场分为医院和零售药店、零售店、在线渠道等。医院和零售药房细分市场在 2019 年占据最大份额;然而,预计在线渠道细分市场在预测期内的复合年增长率最高,为 7.5%。            

        ;                      ;                

产品发布和扩展公司普遍采用战略来扩大其全球足迹和产品组合,并满足不断增长的需求。

非处方药和膳食补充剂市场的市场参与者采用了产品创新战略,以满足世界各地不断变化的客户需求,这也使参与者能够在全球范围内维持其品牌名称。

按产品

< ul>
  • 咳嗽和感冒产品
  • 维生素和膳食补充剂
  • 止痛药
  • 胃肠产品
  • 助眠剂
  • 口腔护理产品
  • 眼科产品
  • 抗酸剂
  • 女性护理
  • 其他

  • 按类型 按类型;                

    • 品牌
    • 通用药


    按剂型

    • 片剂
    • 胶囊
    • 粉剂
    • 软膏
    • 液体
    • 其他


    按分销渠道划分

    • 医院及零售药店
    • 零售店
    • 在线渠道
    • 其他


    按地理位置

    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 法国
      • 德国
      • 意大利
      • 英国
      • 西班牙
    • 亚洲太平洋地区(APAC)
      • 中国
      • 印度
      • 韩国
      • 日本
      • 澳大利亚
      • 中东和中东非洲 (MEA)
        • 南非
        • 沙特阿拉伯
        • 阿联酋
      • 南美洲 (SAM)< ul>
      • 巴西
      • 阿根廷

    公司简介

    • 葛兰素史克公司
    • 赛诺菲
    • 强生服务公司
    • 雅培
    • 艾伯维公司
    • >
    • 鲍什健康公司
    • 拜耳公司
    • 宝洁公司
    • 拜耳公司
    • 宝洁公司赌博
    • 诺华公司
    • 利洁时集团有限公司
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What are the cost benefits of OTC drugs and dietary supplement?

    The use of OTC drugs to treat various health conditions has allowed saving healthcare expenditure. Also, the consumption of dietary supplements has helped in improving health and enhance immunity. Thus, the products have provided affordable treatment options for both consumers and the healthcare systems across the globe.

    What are the driving factors for the OTC drugs and dietary supplementmarketacross the globe?

    The growth of the market is attributed to growing awareness regarding general health issues and growing preference for non-prescription drugs over prescription drugs. However, the stringent FDA regulations related to safety and efficacy of OTC drugs is expected to hinder the market growth.

    What are OTC drugs and dietary supplement?

    Over the counter (OTC) drugs are available for the public for their general use. These drugs do not require a prescription from a physician. OTC medicines are available for various medical symptoms due to medical conditions such as coughs and colds, diarrhea, heartburn, constipation, acne, pain, and others. On the other hand, dietary supplements are available over the counter for fitness purposes. Whereas, in some cases, when a person is critically ill or requires treatment, then buying a dietary supplement with medicinal ingredients requires a prescription from a physician. These OTC drugs and nutritional supplements have two forms, such as branded or generic.

    The List of Companies - OTC Drug and Dietary Supplement Market

    1. GlaxoSmithKline plc.
    2. Sanofi
    3. Johnson and Johnson Services, Inc.
    4. Abbott
    5. AbbVie Inc.
    6. Bausch Health Companies Inc.
    7. Bayer AG
    8. Procter & Gamble
    9. Novartis AG           
    10. Reckitt Benckiser Group Plc

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports